Market Recap — October 25, 2026
Recap of insider activity, SEC filings, and market-moving news for October 25, 2026.
Last generated Nov 2, 2026, 1:03 AM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
A$5.35 Bid Tops Warburg's Offer in $1.6B Ingenia Takeover Fight
Bon Secours Nears $6B Takeover of Surgery Partners
Borr Drilling Rig Sinks Off During Preload; Five Workers Missing
Sone-Ve Cuts Death Risk 42% in Late-Line Gastric Cancer, PFS Endpoint Missed
Divarasib Cuts Death Risk 44% vs Standard KRAS Drugs in Phase III Lung Cancer Trial
Foldable iPhone Duo Sells Out at Launch; Apple Reportedly Boosts Orders 30%
Glass Lewis Backs Full DGB Slate in Ethan Allen Proxy Fight
Netflix Engagement Data Show Subscribers Watching Less, Opening App Less Often
Ivonescimab Beats Durvalumab in Biliary Tract Cancer: OS 14.9 vs 12.1 Months
NovaBridge Picks 8 mg/kg Givastomig Dose After FDA Aligns on Phase 3
72% pCR in 18-Patient dMMR Colon Cancer Cohort for BOT+BAL
Xencor Locks Phase 3 Dose for XmAb819 After 45.5% Response Rate in Kidney Cancer
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
A$5.35 Bid Tops Warburg's Offer in $1.6B Ingenia Takeover Fight
Bon Secours Nears $6B Takeover of Surgery Partners
Borr Drilling Rig Sinks Off During Preload; Five Workers Missing
Sone-Ve Cuts Death Risk 42% in Late-Line Gastric Cancer, PFS Endpoint Missed
Divarasib Cuts Death Risk 44% vs Standard KRAS Drugs in Phase III Lung Cancer Trial
Foldable iPhone Duo Sells Out at Launch; Apple Reportedly Boosts Orders 30%
Glass Lewis Backs Full DGB Slate in Ethan Allen Proxy Fight
Netflix Engagement Data Show Subscribers Watching Less, Opening App Less Often
Ivonescimab Beats Durvalumab in Biliary Tract Cancer: OS 14.9 vs 12.1 Months
NovaBridge Picks 8 mg/kg Givastomig Dose After FDA Aligns on Phase 3
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.